Peter A Thompson Insider Trading $RPBIF RESPONSE BIOMEDICAL CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Peter A Thompson.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Peter A Thompson. Peter A Thompson is Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in ProNAi Therapeutics Inc ($DNAI) and President and CEO in Trubion Pharmaceuticals, Inc ($TRBN) and President, CEO & Treasurer in Trubion Pharmaceuticals, Inc ($TRBN) and Director in Synthorx, Inc. ($THOR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Prevail Therapeutics Inc. ($PRVL) and Director in Edgewise Therapeutics, Inc. ($EWTX).

Peter A Thompson in RESPONSE BIOMEDICAL CORP

Trading Symbol: RPBIF
Industry: SERVICES-TESTING LABORATORIES [8734]
Position of Peter A Thompson: Director
Holdings: 0 shares
Latest Transaction: Dec 01 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Peter A Thompson in RESPONSE BIOMEDICAL CORP

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADAP, ALPN, CRVS, DBTX, EWTX, PMVP, PRVL, RPBIF, SRRA, SBTX, THOR, TRBN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorOption ExerciseD0.855,0004,2500
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorOption ExerciseD0.925,0004,6000
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorOption ExerciseD1.435,0007,1500
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorOption ExerciseD3.1020,00062,0000
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorOption ExerciseD1.0220,00020,4000
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorOption ExerciseD2.20166,666366,6650
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorSellJ0.002,149,902002.1 M to 0 (-100.00 %)
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorSellJ0.0034,2910034.3 K to 0 (-100.00 %)
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorSellJ0.003,604,266003.6 M to 0 (-100.00 %)
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorSellJ0.0096,8840096.9 K to 0 (-100.00 %)
Jun 20 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorBuyP0.56331,225185,4862,149,9021.8 M to 2.1 M (+18.21 %)
Jun 20 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorBuyP0.565,2942,96534,29129 K to 34.3 K (+18.26 %)
Jun 20 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorBuyP0.56556,339311,5503,604,2663 M to 3.6 M (+18.25 %)
Mar 28 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorOption ExerciseA0.855,0004,2505,000
Mar 28 2016RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorGrantA0.0037,058096,88459.8 K to 96.9 K (+61.94 %)
May 21 2015RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorGrantA0.0010,511059,82649.3 K to 59.8 K (+21.31 %)
Mar 23 2015RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorOption ExerciseA0.925,0004,6005,000
Mar 23 2015RPBIFRESPONSE BIOMEDICA ...Thompson Peter A.DirectorGrantA0.008,860049,31540.5 K to 49.3 K (+21.90 %)

Page:   1